Christopher Davitt

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (31)

• Supplementary Appendix S1 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.30095452
  +Save
• Supplementary Table S4 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.28332754
  +Save
• Supplementary Table S3 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.28332757
  +Save
• Supplementary Table S2 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.28332760
  +Save
• Supplementary Table S1 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.28332766
  +Save
• Supplementary Figure S4 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.28332769
  +Save
• Supplementary Figure S3 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.28332775
  +Save
• Supplementary Figure S2 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.28332778
  +Save
• Supplementary Figure S1 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.28332781
  +Save
• Supplementary Appendix S1 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
  2025 DOI: 10.1158/1078-0432.28332784
  +Save